Please login to the form below
Roche, J&J and Novartis in hepatitis C diagnostics tie-up
Roche signs licensing agreements for Hepatitis C immunodiagnostics with J&J subsidiary Ortho-Clinical Diagnostics and Novartis
Swiss-based pharmaceutical group Roche has signed licensing agreements for Hepatitis C immunodiagnostics with J&J subsidiary Ortho-Clinical Diagnostics and Swiss-headquartered Novartis.
Roche, Ortho-Clinical and Novartis also agreed to settle all litigation related to licensed patents.
Roche will receive a worldwide royalty-bearing license under the deal, according to a Roche statement. Financial terms were not disclosed.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- How will the events and exhibitions industry change post-Coronavirus?
- Finalists 2020 - Communiqué Awards
- Syneos Health appoints trio of senior hires
- Abivax doses first patient in phase 2b/3 COVID-19 clinical trial
- Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK
- Windrose Consulting Group acquires Parioforma as part of its global growth strategy to further enhance its capabilities in non-traditional markets
- Spirit Shorts #1 - Effective presentations
- Epilepsy Day 2020 at Spirit Group
- ISMPP EU 2020 Summary: RWE roundtable
- ISMPP Live Update: Plain Language Summaries
- ISMPP EU 2020 Summary: Precision Communications
PMHub
Weber Shandwick
At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...
Latest intelligence
- The search for treatments for Parkinson’s disease
- The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
- Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
- Ditch the Label – it’s just me....
- The impact of COVID-19 on clinical trials
- As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...
Quick links
Infographics
